Six case reports of NTHL1-associated tumor syndrome further support it as a multi-tumor predisposition syndrome
- PMID: 36196035
- DOI: 10.1111/cge.14242
Six case reports of NTHL1-associated tumor syndrome further support it as a multi-tumor predisposition syndrome
Abstract
NTHL1-associated tumor syndrome (NATS) is an autosomal recessive condition characterized by an increased risk for colorectal polyposis and colorectal cancer (CRC). Only 46 case reports have been previously published. In a retrospective review, we analyzed the clinical histories of six patients found to have NATS after genetic counseling and testing. NATS appears to be associated with an increased risk for colorectal polyposis, CRC, female breast cancer, meningiomas, and endometrial cancer. Although research is limited, prior publications have reported a multi-tumor predisposition for individuals with biallelic pathogenic or likely pathogenic variants in NTHL1. Additional data are necessary to further define the cancer risks so affected individuals can be appropriately managed.
Keywords: NTHL1; NTHL1-associated tumor syndrome; breast cancer; cancer genetics; colorectal cancer; genetic predisposition; hereditary; meningioma; polyposis.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.Sci Rep. 2019 Jun 21;9(1):9020. doi: 10.1038/s41598-019-45281-1. Sci Rep. 2019. PMID: 31227763 Free PMC article.
-
Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.Clin Genet. 2021 May;99(5):662-672. doi: 10.1111/cge.13925. Epub 2021 Feb 12. Clin Genet. 2021. PMID: 33454955
-
Intestinal and extraintestinal neoplasms in patients with NTHL1 tumor syndrome: a systematic review.Fam Cancer. 2022 Oct;21(4):453-462. doi: 10.1007/s10689-022-00291-3. Epub 2022 Mar 16. Fam Cancer. 2022. PMID: 35292903 Review.
-
The role of inherited genetic variants in colorectal polyposis syndromes.Adv Genet. 2019;103:183-217. doi: 10.1016/bs.adgen.2018.11.002. Epub 2019 Jan 22. Adv Genet. 2019. PMID: 30904095 Review.
-
NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?J Pathol. 2018 Feb;244(2):135-142. doi: 10.1002/path.5002. Epub 2017 Dec 14. J Pathol. 2018. PMID: 29105096 Review.
Cited by
-
Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes.Curr Issues Mol Biol. 2024 Jun 26;46(7):6440-6471. doi: 10.3390/cimb46070385. Curr Issues Mol Biol. 2024. PMID: 39057027 Free PMC article. Review.
-
NTHL1 is a recessive cancer susceptibility gene.Sci Rep. 2023 Nov 30;13(1):21127. doi: 10.1038/s41598-023-47441-w. Sci Rep. 2023. PMID: 38036545 Free PMC article.
-
Combined germline and tumor mutation signature testing identifies new families with NTHL1 tumor syndrome.Front Genet. 2023 Aug 31;14:1254908. doi: 10.3389/fgene.2023.1254908. eCollection 2023. Front Genet. 2023. PMID: 37727376 Free PMC article.
References
REFERENCES
-
- Weren RD, Ligtenberg MJ, Kets CM, et al. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet. 2015;47(6):668-671. doi:10.1038/ng.3287
-
- Rivera B, Castellsagué E, Bah I, van Kempen LC, Foulkes WD. Biallelic NTHL1 mutations in a woman with multiple primary tumors [published correction appears in N Engl J Med. 2015 Dec 17;373(25):e33]. N Engl J Med. 2015;373(20):1985-1986. doi:10.1056/NEJMc1506878
-
- Belhadj S, Mur P, Navarro M, et al. Delineating the phenotypic Spectrum of the NTHL1-associated polyposis. Clin Gastroenterol Hepatol. 2017;15(3):461-462. doi:10.1016/j.cgh.2016.09.153
-
- Broderick P, Dobbins SE, Chubb D, et al. Validation of recently proposed colorectal cancer susceptibility gene variants in an analysis of families and patients-a systematic review. Gastroenterology. 2017;152(1):75-77.e4. doi:10.1053/j.gastro.2016.09.041
-
- Grolleman JE, de Voer RM, Elsayed FA, et al. Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype. Cancer Cell. 2019;35(2):256-266.e5. doi:10.1016/j.ccell.2018.12.011
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical